Physiologically‐Based Pharmacokinetic Modeling Characterizes the CYP3A‐Mediated Drug‐Drug Interaction Between Fluconazole and Sildenafil in Infants is a research paper published in Clinical Pharmacology & Therapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 40 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Child Health and Human Development
Grant: HHSN275201000003I
National Institute of Child Health and Human Development
Grant: HHSN275201700002C
National Institute of Child Health and Human Development
Grant: T32GM086330
National Institute of Child Health and Human Development
Grant: K23HD083465
National Institute of Child Health and Human Development
Grant: R01HD096435
National Institute of General Medical Sciences
Grant: T32GM122741
U.S. Food and Drug Administration
Grant: R01FD006099
U.S. Food and Drug Administration
Grant: K24HL143283
NICHD NIH HHS
Grant: HHSN275201000003C
National Institutes of Health
Grant: 5T32GM086330-08
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
National Institutes of Health
Grant: 1R01HD096435-01
Physiologically-Based Pharmacokinetic Modeling to Guide Drug Dosing in Children with Obesity
National Institutes of Health
Grant: 5T32GM122741-05
Enhancement Training for the Next Generation of Translational Ph.D. Scientists
National Institutes of Health
Grant: 1R01FD006099-01
Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia
National Institutes of Health
Grant: 5K23HD083465-05
Use of Physiologically-Based PK/PD Models to Streamline Drug Approvals
National Institutes of Health
Grant: 1K24HL143283-01A1
Mentorship of Early-Career Clinicians in Bronchopulmonary Dysplasia Drug Therapies
FWCI
8.63
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Prediction of drug–drug interactions between roflumilast and CYP3A4/1A2 perpetrators using a physiologically-based pharmacokinetic (PBPK) approach
Additional file 1 of Prediction of drug–drug interactions between roflumilast and CYP3A4/1A2 perpetrators using a physiologically-based pharmacokinetic (PBPK) approach